Chinese version of fear of cancer recurrence questionnaire for cancer patients: a preliminary study

doi:10.3877/cma.j.issn.2095-9133.2019.03.007

Abstract

Abstract:

Objective

To translate the English version of the Fear of Cancer Recurrence Questionnaire(FCRQ)into Chinese and to test its validity and reliability among Chinese cancer patients.

Methods

After we achieved a draft Chinese version, we recruited 571 cancer patients (52 males and 519 females, mean age: 47.50±11.43 years, range from 21 to 88 years) from Southern Medical University Nanfang Hospital, Guangdong Provincial People’s Hospital and Guangzhou Women and Children’s Medical Center and asked them to complete the FCRQ, the Fear of Progression Questionnaire – Short Form(FoP-Q-SF), the Patient Health Questionnaire(PHQ-9) and the General Anxiety Disorder Questionnaire(GAD-7). Cronbach’s alpha was calculated and Explorary Factorial Analysis(EFA)was conducted. Fifty percent of the participants were randomly selected and re-contacted after one month to explore the test-retest reliability.

Results

The Cronbach’s alpha of the Chinese FCRQ scale was 0.86, Spearman Brown coefficient was 0.89, and the test-retest coefficient was 0.90. EFA revealed that the scale was a single factor instrument, and it explained up to 65.91% of the total variance. The r value between scale item and total score ranged from 0.575 to 0.876, and their loadings showed satisfactory outcomes (ranged from 0.787 to 0.894)except for item 6(loading=0.577). The FCRQ showed significant correlation with FoP-Q-SF, PHQ9 and GAD7 scales(r values ranged from 0.524-0.758).

Conclusion

The Chinese version FCRQ is reliable and could be utilized in the field of cancer research.

Key words: Neoplasm, Scale, Reliability, Validity, Fear of recurrence

Yongfu Zhang, Xiaomin Tan, Hengwen Sun, Zhihui Sun, Jingying Zhang, Ting Liu, Hongmei Wang, Weijiang Liang, Yuan Yang. Chinese version of fear of cancer recurrence questionnaire for cancer patients: a preliminary study[J]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2019, 05(03): 157-163.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwsyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9133.2019.03.007

https://zhwsyjdzzz.cma-cmc.com.cn/EN/Y2019/V05/I03/157

Figures/Tables 6

References 33

1	Simard S, Thewes B, Humphris G, et al.Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies[J]. J Cancer Surviv, 2013, 7(3): 300-322.
2	Custers JA, Tielen R, Prins JB, et al.Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles？[J]. Acta Oncol, 2015, 54(8): 1202-1208.
3	Llewellyn CD, Weinman J, McGurk M, et al.Can we predict which head and neck cancer survivors develop fears of recurrence？[J]. J Psychosom Res, 2008, 65(6): 525-532.
4	Lebel S, Ozakinci G, Humphris G, et al.From normal response to clinical problem: definition and clinical features of fear of cancer recurrence[J]. Support Care Cancer, 2016, 24(8): 3265-3268.
5	Härtl K, Janni W, Kästner, et al.Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients[J]. Ann Oncol, 2003, 14(7): 1064-1071.
6	Lebel S, Beattie S, Arès I, et al.Young and worried: Age and fear of recurrence in breast cancer survivors[J]. Health Psychol, 2013, 32(6): 695-705.
7	Avis NE, Smith KW, McGraw S, et al.Assessing quality of life in adult cancer survivors(QLACS)[J]. Qual Life Res, 2005, 14(4): 1007-1023.
8	Black EK, White CA.Fear of recurrence, sense of coherence and posttraumatic stress disorder in haematological cancer survivors[J]. Psychooncology, 2005, 14(6): 510-515.
9	Lebel S, Rosberger Z, Edgar L, et al.Emotional distress impacts fear of the future among breast cancer survivors not the reverse[J]. J Cancer Surviv, 2009, 3(2): 117-127.
10	张阳，田丽，高月乔，等．癌症患者复发恐惧的研究进展[J]．中华护理杂志，2017，52(8)：997-1001.
11	吴奇云，叶志霞，李丽．癌症患者恐惧癌症复发的测量及影响因素研究进展[J]．中国护理管理，2015，15(8)：1020-1023.
12	Koch L, Jansen L, Brenner H, et al.Fear of recurrence and disease progression in long-term(≥ 5 years)cancer survivors--a systematic review of quantitative studies[J]. Psychooncology, 2013, 22(1): 1-11.
13	Mehnert A, Herschbach P, Berg P, et al.[Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)][J]. Z Psychosom Med Psychother, 2006, 52(3): 274-288.
14	Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence[J]. Support Care Cancer, 2009, 17(3): 241-251.
15	焦玮，曹湘博，聂刚，等．癌症焦虑量表在乳腺癌患者术后复发恐惧检测中的应用[J]．中华现代护理杂志，2014，20(36)：4571-4572.
16	吴奇云，叶志霞，李丽．癌症患者恐惧疾病进展简化量表的汉化及信效度分析[J]．中华护理杂志，2015，50(12)：1515-1519.
17	Humphris GM, Watson E, Sharpe M, et al.Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7[J]. Health Qual Life Outcomes, 2018, 16(1): 30.
18	Spitzer RL, Kroenke K, Williams JB.Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study.Primary care evaluation of mental disorders.Patient health questionnaire[J]. JAMA, 1999, 282(18): 1737-1744.
19	Kroenke K, Spitzer RL, Williams JB, et al.The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review[J]. Gen Hosp Psychiatry, 2010, 32(4): 345-359.
20	陈曼曼，胜利，曲姗．病人健康问卷在综合医院精神科门诊中筛查抑郁障碍诊断试验[J]．中国心理卫生杂志，2015，29(4)：163-168.
21	Spitzer RL, Kroenke K, Williams JB, et al.A brief measure for assessing generalized anxiety disorder: the GAD-7[J]. Arch Intern Med, 2006, 166(10): 1092-1097.
22	曾庆枝，何燕玲，刘寒．广泛性焦虑量表中文版在中医内科门诊人群应用的信度和效度[J]．中国心理卫生杂志，2013，27(3)：163-168.
23	Waltz CF.Educational outcomes: assessment of quality—a prototype for student outcome measurement in nursing programs[J]. NLN Publ, 1988, (18-2255): 1-36.
24	吴明隆．问卷统计分析实务[M]．重庆：重庆大学出版社，2014：181.
25	Liao KY, Yeung NC, Wong CC, et al.Fear of cancer recurrence and physical well-being among Chinese cancer survivors: the role of conscientiousness, positive reappraisal and hopelessness[J]. Support Care Cancer, 2017, 25(4): 1141-1149.
26	Ashing KT, Cho D, Lai L, et al.Exploring characteristics, predictors, and consequences of fear of cancer recurrence among Asian-American breast cancer survivors[J]. Psychooncology, 2017, 26(12): 2253-2260.
27	Thewes B, Butow P, Zachariae R, et al.Fear of cancer recurrence: a systematic literature review of self-report measures[J]. Psychooncology, 2012, 21(6): 571-587.
28	Polit DF, Beck CT.International gender bias in nursing research, 2005-2006: a quantitative content analysis[J]. Int J Nurs Stud, 2009, 46(8): 1102-1110.
29	Cronbach LJ, Warrington WG.Time-limit tests: estimating their reliability and degree of speeding[J]. Psychometrika, 1951, 16(2): 167-188.
30	李肖静，史云菊．护士实践量表的汉化及信效度检验[J]．中华护理杂志，2016，51(8)：1009-1011.
31	Comrey A. A first course in factor analysis[M]. New York: Academic Press, 1973: 78-79.
32	Lasry JC, Margolese RG.Fear of recurrence, breast-conserving surgery, and the trade-off hypothesis[J]. Cancer, 1992, 69(8): 2111-2115.
33	Simard S, Savard J, Ivers H. Fear of cancer recurrence: specific profiles and nature of intrusive thoughts[J]. Cancer Surviv, 2010, 4(4): 361-371.

组别	例数	年龄(岁)	性别(男/女)	婚姻状态(是/否)	教育程度(中学及以下/本科/研究生)	就业状况(全职/兼职/无业)	接受手术(是/否)	接受化疗(是/否)	接受放疗(是/否)	其他身体疾病(是/否)	癌症家族史(是/否)
初测	571	47.5±11.4	9.1/90.9	85.5/14.5	65.3/32.1/2.6	39.8/6.3/53.9	87.2/12.8	86.0/14.0	87.2/12.8	62.7/37.3	26.8/73.2
复测	285	46.7±11.1	7.0/93.0	87.4/12.6	63.9/30.1/6.0	39.3/7.0/53.7	90.5/9.5	84.9/15.1	85.6/14.4	67.0/33.0	25.6/74.4
t/χ²值	?	1.05	1.08	0.58	5.94	0.16	2.02	0.18	0.42	1.54	0.14
P值	?	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	年龄(岁)	性别(男/女)	婚姻状态(是/否)	教育程度(中学及以下/本科/研究生)	就业状况(全职/兼职/无业)	接受手术(是/否)	接受化疗(是/否)	接受放疗(是/否)	其他身体疾病(是/否)	癌症家族史(是/否)
初测	571	47.5±11.4	9.1/90.9	85.5/14.5	65.3/32.1/2.6	39.8/6.3/53.9	87.2/12.8	86.0/14.0	87.2/12.8	62.7/37.3	26.8/73.2
复测	285	46.7±11.1	7.0/93.0	87.4/12.6	63.9/30.1/6.0	39.3/7.0/53.7	90.5/9.5	84.9/15.1	85.6/14.4	67.0/33.0	25.6/74.4
t/χ²值	?	1.05	1.08	0.58	5.94	0.16	2.02	0.18	0.42	1.54	0.14
P值	?	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	条目1	条目2	条目3	条目4	条目5	条目6	条目7
高分组	571	3.87±0.86	3.72±0.82	3.46±0.74	2.82±0.98	3.18±0.78	3.54±0.82	6.98±2.14
低分组	571	1.91±0.72	1.75±0.61	1.85±0.53	1.26±0.45	1.58±0.61	2.33±0.91	1.94±1.03
t值	?	－23.95	－26.36	－24.16	－19.92	－21.86	－13.52	－29.15
P值	?	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05
95%CI	?	－2.12～－1.79	－2.12～－1.82	－1.73～－1.47	－1.71～－1.4	－1.74～－1.45	－1.39～－1.04	－5.37～－4.69

组别	例数	条目1	条目2	条目3	条目4	条目5	条目6	条目7
高分组	571	3.87±0.86	3.72±0.82	3.46±0.74	2.82±0.98	3.18±0.78	3.54±0.82	6.98±2.14
低分组	571	1.91±0.72	1.75±0.61	1.85±0.53	1.26±0.45	1.58±0.61	2.33±0.91	1.94±1.03
t值	?	－23.95	－26.36	－24.16	－19.92	－21.86	－13.52	－29.15
P值	?	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05	<0.05
95%CI	?	－2.12～－1.79	－2.12～－1.82	－1.73～－1.47	－1.71～－1.4	－1.74～－1.45	－1.39～－1.04	－5.37～－4.69

组别	例数(例)	条目1	条目2	条目3	条目4	条目5	条目6	条目7	FCRQ总分
初测	571	2.84±0.94	2.67±0.95	2.59±0.82	1.97±0.89	2.34±0.83	2.83±0.89	4.79±2.22	20.02±5.81
复测	285	2.76±0.86	2.64±0.90	2.84±0.82	1.96±0.85	2.37±0.81	2.94±0.85	4.75±2.22	19.95±5.52
t值	?	－1.02	－0.45	－0.72	－0.14	0.46	1.5	－0.23	－0.16
P值	?	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05
r值	?	0.79^**	0.83^**	0.80^**	0.82^**	0.82^**	0.77^**	0.87^**	0.90^**

Please choose a citation manager

Content to export